REPAGLINIDE 0.5, 1, 2 mg (2017-04-21)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II
| Lot or serial number | Companies | Brand name | Dosage form | DIN, NPN, DIN-HIM | Strength |
|---|
| 1600516 | - Recalling Firm
- Pro Doc Ltd.
- 2925 Industrial Blvd.
- Laval
- H7L 3W9
- Quebec
- CANADA
- Marketing Authorization Holder
- Pro Doc Ltd.
- 2925 Industrial Blvd.
- Laval
- H7L 3W9
- Quebec
- CANADA
| B. REPAGLINIDE 1 mg | Tablet | DIN 02415976 | REPAGLINIDE 1 mg |
| 1600540 | - Recalling Firm
- Pro Doc Ltd.
- 2925 Industrial Blvd.
- Laval
- H7L 3W9
- Quebec
- CANADA
- Marketing Authorization Holder
- Pro Doc Ltd.
- 2925 Industrial Blvd.
- Laval
- H7L 3W9
- Quebec
- CANADA
| REPAGLINIDE 2 mg | Tablet | DIN 02415984 | 2 mg Repaglinide |
| 1505632 | - Recalling Firm
- Pro Doc Ltd.
- 2925 Industrial Blvd.
- Laval
- H7L 3W9
- Quebec
- CANADA
- Marketing Authorization Holder
- Pro Doc Ltd.
- 2925 Industrial Blvd.
- Laval
- H7L 3W9
- Quebec
- CANADA
| REPAGLINIDE 0.5 mg | Tablet | DIN 02415968 | 1 mg Repaglinide |
Affected Products
-
REPAGLINIDE 0.5 mg
-
REPAGLINIDE 1 mg
-
REPAGLINIDE 2 mg
Out of specification for degradation product during stability program